Abstract: The integration of unmanned aerial vehicles (UAVs) and deep learning technologies has become increasingly prevalent in the inspection of transmission lines. However, the existing methods ...

Play too much Factorio, and you'll start seeing conveyor belts in your dreams. There's something mesmerizing about a sprawling network of production lines, and they sear themselves into your eyeballs ...

Take a look at the Substructure announcement trailer for this upcoming factory and automation game from the creator of UltraCube (a Factorio mod). Substructure will be available in PC Early Access.

Play alone, or face the unknown terrors below with your bravest friends. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. From the minds that ...

Pangea’s purchase of Overlap is an early wager that social trip-planning tools belong on a single platform — not scattered among dozens of niche apps. Pangea, a travel technology platform aimed at ...

For architects and specifiers, selecting the right cladding system is both a technical and creative act, connecting material science with architectural intent. More than simple visual envelopes, ...

Optimal Blue CEO Joe Tyrrell has responded to a class action lawsuit alleging mortgage price-fixing, calling the claims baseless and frivolous. The company, along with 26 major lenders, is accused of ...

Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. Launch monitors have changed the game. Golfers can now see every number ...

The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...

You’ve spent all the money, all the time, and all the energy planning for this: your son’s 11th birthday party. The gathering went off surprisingly well; everyone seemed to have a good time, and the ...

Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody. Analysts praised the ...